BCTX

BriaCell Therapeutics Corporation
7.06
0.23 (3.37%)

BriaCell Therapeutics Corp. (BCTX) Fundamentals

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell is conducting a Phase II clinical trial of Bria-IMT in metastatic advanced breast cancer (Fast Track designation from FDA). BriaCell is developing Bria-OTS, a personalized off the shelf immunotherapy for cancer based on matching the patient's HLA type. Enhanced cellular immunotherapies with enhanced potency are under development.
SHARE INFORMATION
Market Cap$ 105,988,063
Shares Outstanding15,518,018
Float13,384,330
Percent Float86.25%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.38
Latest Fiscal Date2022-07-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions32
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months757,736
Institutional Holdings Percent19.1%
Institutional Sold Previous 3 Months1,142,805
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months52,530
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 12.09
52 Week Low$ 4.06
52 Week High Change$ 5.40
21 Day Moving Average$ 6.7112
21 Day Extended Moving Average$ 6.7682
50 Day Moving Average$ 5.932
50 Day Extended Moving Average$ 6.2641
200 Day Moving Average$ 6.1294
200 Day Extended Moving Average$ 6.3357
10 Day Average Volume242,595
20 Day Average Volume283,781
30 Day Average Volume254,035
50 Day Average Volume224,164
Alpha9.524864
Beta-28.6967
Standard Deviation72.125832
R20.000462
7 Day Price Change$ -0.70
7 Day Percent Change-9.3%
21 Day Price Change$ 0.26
21 Day Percent Change3.96%
30 Day Price Change$ 2.46
30 Day Percent Change56.29%
Month to Date Price Change$ -0.65
Month to Date Percent Change-8.69%
Quarter to Date Price Change$ 2.46
Quarter to Date Percent Change56.29%
180 Day Price Change$ 0.27
180 Day Percent Change4.12%
200 Day Price Change$ 0.75
200 Day Percent Change12.34%
Year to Date Price Change$ 2.46
Year to Date Percent Change56.29%

BriaCell Therapeutics Corp. (BCTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book11.00
Total Debt To Equity0.00
Int Coverage-27,413.60
Current Ratio39.20
Leverage Ratio3.90
Quick Ratio38.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-4.70
Enterprise Value$ 60,650,963
Price to Sales0.00
Price to Free Cash-10.10
PE High Last 5 Years-1.50
Price To Book11.20
Price To Cash Flow0.00
PE Low Last 5 Years-3.20
Price to Tangible Book11.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-0.92
Return on Equity-1.36
Return on Capital-2.22

BriaCell Therapeutics Corp. (BCTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMeyers Norris Penny LLP
CEOWilliam Williams
Emplyoees12
Last AuditUQ
CIK0001610820
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address235 - 15th Street
Suite 300, West Vancouver
Vancouver, BC V7T 2X1
Websitehttps://www.briacell.com
Facsimile+1 424 245-3719
Telephone+1 888 485-6340
Email-


Your Recent History
NASDAQ
BCTX
BriaCell T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.